Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

NCT06712316 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

1260

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: Pumitamig
DRUG: Pembrolizumab
DRUG: Carboplatin
DRUG: Pemetrexed
DRUG: Paclitaxel

Sponsor

BioNTech SE

Collaborators

[object Object]